Revisions of international consensus Fukuoka guidelines for the management of IPMN of the pancreas

M Tanaka, C Fernández-del Castillo, T Kamisawa… - Pancreatology, 2017 - Elsevier
The management of intraductal papillary mucinous neoplasm (IPMN) continues to evolve. In
particular, the indications for resection of branch duct IPMN have changed from early …

[HTML][HTML] International evidence-based Kyoto guidelines for the management of intraductal papillary mucinous neoplasm of the pancreas

T Ohtsuka, C Fernandez-del Castillo, T Furukawa… - Pancreatology, 2024 - Elsevier
This study group aimed to revise the 2017 international consensus guidelines for the
management of intraductal papillary mucinous neoplasm (IPMN) of the pancreas, and …

Pancreatic cysts

TA Gonda, DL Cahen, JJ Farrell - New England Journal of …, 2024 - Mass Medical Soc
Key Points Pancreatic Cysts Pancreatic cysts are common and are being discovered at an
increasing rate on cross-sectional imaging, but only a minority progress to cancer. The most …

Diagnosis and management of pancreatic cystic neoplasms: current evidence and guidelines

NCM Van Huijgevoort, M Del Chiaro… - Nature reviews …, 2019 - nature.com
Pancreatic cystic neoplasms (PCN) are a heterogeneous group of pancreatic cysts that
include intraductal papillary mucinous neoplasms, mucinous cystic neoplasms, serous cystic …

Association of high-risk stigmata and worrisome features with advanced neoplasia in intraductal papillary mucinous neoplasms (IPMN): A systematic review

E Ohno, A Balduzzi, S Hijioka, M De Pastena… - Pancreatology, 2024 - Elsevier
Background This systematic review aimed to assess the diagnostic accuracy of the
International Consensus Fukuoka Guidelines (ICG2017) in identifying high-risk lesions of …

Pathologic evaluation and reporting of intraductal papillary mucinous neoplasms of the pancreas and other tumoral intraepithelial neoplasms of pancreatobiliary tract …

V Adsay, M Mino-Kenudson, T Furukawa… - Annals of …, 2016 - journals.lww.com
Background: There are no established guidelines for pathologic diagnosis/reporting of
intraductal papillary mucinous neoplasms (IPMNs). Design: An international …

Low progression of intraductal papillary mucinous neoplasms with worrisome features and high-risk stigmata undergoing non-operative management: a mid-term …

S Crippa, C Bassi, R Salvia, G Malleo, G Marchegiani… - Gut, 2017 - gut.bmj.com
Objective To evaluate mid-term outcomes and predictors of survival in non-operated patients
with pancreatic intraductal papillary mucinous neoplasms (IPMNs) with worrisome features …

Systematic review of challenging issues in pathology of intraductal papillary mucinous neoplasms

LD Wood, NV Adsay, O Basturk, LAA Brosens… - Pancreatology, 2023 - Elsevier
Abstract Background/Objectives: Intraductal papillary mucinous neoplasms (IPMNs) are a
cystic precursor to pancreatic cancer. IPMNs deemed clinically to be at high-risk for …

Risk of the watch-and-wait concept in surgical treatment of intraductal papillary mucinous neoplasm

C Tjaden, M Sandini, AL Mihaljevic, J Kaiser… - JAMA …, 2021 - jamanetwork.com
Importance The natural history of intraductal papillary mucinous neoplasms (IPMNs)
remains uncertain. The inconsistencies among published guidelines preclude accurate …

Active surveillance beyond 5 years is required for presumed branch-duct intraductal papillary mucinous neoplasms undergoing non-operative management

S Crippa, R Pezzilli, M Bissolati… - Official journal of the …, 2017 - journals.lww.com
Objectives: To evaluate the results of active surveillance beyond 5 years in patients with
branch-duct intraductal papillary mucinous neoplasms (BD-IPMNs) without worrisome …